$148 Billion is the total value of Meditor Group Ltd's 4 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXEL | Sell | EXELIXIS INC | $105,947,183 | +99028.2% | 6,605,186 | -3.1% | 71.63% | +0.8% |
| ESPR | ESPERION THERAPEUTICS INC | $27,840,842 | +92885.7% | 4,468,835 | 0.0% | 18.82% | -5.5% | |
| INDA | ISHARES MSCI INDIA ETF | $7,145,888 | +102262.0% | 171,200 | 0.0% | 4.83% | +4.0% | |
| EPI | WISDOMTREE INDIA EARNINGS FUND | $6,967,742 | +106619.9% | 213,800 | 0.0% | 4.71% | +8.5% |
The following EDGAR filing(s) were analyzed to create this report:
The EDGAR filing(s) were signed by:
- Brian Desmond — Director, Meditor Group Limited
- Meditor Group Ltd holdings (13F-HR)
- Meditor Group Ltd significant holdings (13D/G)
- Meditor Group Ltd ownership history
- Meditor Group Ltd portfolio value
- Meditor Group Ltd filings
- Similar filers BETA
Compare quarterly holdings
Export Meditor Group Ltd's holdings